ANGIOSTOMY CANNULA MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2025-2032)

An angiostomy cannula is a thin tube that is inserted into the human body’s veins or body cavity to introduce medication, remove fluid or insert a surgical instrument. The cannula is usually surrounded by the trocar needle’s inner and outer surfaces, which allow puncturing of the body in order to get enough space. It is also known as an intravenous IV cannula. The normal cannula size mainly ranges from 14 to 24 gauge. There are various types of cannula such as venous cannula, arterial cannula, nasal cannula or an oral-nasal cannula. The venous cannula is used for inserting into veins for the removal of blood samples and for administering medicines. An arterial cannula is used to insert into the artery of the human body, commonly in the radial artery, during major operations such as bypass surgery and is also used to measure beat to beat blood pressure, which is a painful procedure that leads to stress and anxiety. The nasal cannula, or oral nasal cannula, is used to insert into the nostrils and mouth, as well as for delivering oxygen or measuring the airflow into the nose.

On the basis of size, it is differentiated into colours such as orange (14G), grey (16G), green (18G), pink (20G), blue (22G), yellow (24G), and violet (26G). The use of these various sizes of cannula depends on the patient’s age, physique, and the application of the cannula. The materials that are used to make cannulas are plastic, metal, and silicon, as the silicon material is expected to support the growth of the cannula market, as this type of cannula is more flexible and soft to use.   

Market Dynamics

The increasing geriatric population across the globe is expected to drive growth of the global angiostomy cannula market. According to the data shared in April 2023 by the United Nations- an intergovernmental organization whose stated purposes are to maintain international peace and security, develop friendly relations among nations, achieve international cooperation, and serve as a centre for harmonizing the actions of nations, 9.8% of the world population was elderly population in the year 2022.

Key features of the study:

• This report provides an in-depth analysis of the global angiostomy cannula market and provides market size (US$ Mn) and compound annual growth rate (CAGR) for the forecast period 2025-2032, considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global angiostomy cannula market based on the following parameters– company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Smith+Nephew, Maquet Holding B.V. & Co. KG. (A subsidiary of Getinge), LivaNova PLC (Formed from the merger of Sorin group and Cyberonics, Inc.), Edwards Lifesciences Corporation, Medtronic, Merck & Co., Inc., Terumo Corporation, Medline Industries, LP, Cardinal Health, Boston Scientific Corporation, Teleflex Incorporated, Dolphin surgical industries, Goodhealth Inc., and BioTek Instruments, Inc. (A subsidiary of Agilent Technologies, Inc.)
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• Global angiostomy cannula market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global angiostomy cannula market.

Detailed Segmentation:

• Global Angiostomy Cannulas Market, By Type:
  • Cardiac cannula
  • Vascular cannula
  • Arthroscopy cannula
  • Dermatology cannula
  • Nasal cannula
  • Floating spinal cannula
  • Vitreoretinal cannula
  • Hysterosalpingography cannula
• Global Angiostomy Cannulas Market, By Application :
  • Cardiovascular Surgery
  • Oxygen Therapy
  • Orthopedic Surgery
  • Diabetes treatment
  • Neurology
  • General Surgery
  • Cosmetic/Plastic Surgery
• Global Angiostomy Cannulas Market, By End user:
  • Hospitals
  • Ambulatory Surgical Centers
  • Blood Banks
  • Home Healthcare Facilities
• Global Angiostomy Cannula Market, By Region:
  • North America
    
    • U.S.
    • Canada
  • Latin America
    
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
  • Europe
    
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
  • Middle East
    
    • GCC
    • Israel
    • Rest of Middle East
  • Africa
    
    • South Africa
    • Central Africa
    • North Africa
• Company Profiles
  • Smith+Nephew
  • Maquet Holding B.V. & Co. KG. (A subsidiary of Getinge)
  • LivaNova PLC (Formed from the merger of Sorin group and Cyberonics, Inc.)
  • Edwards Lifesciences Corporation
  • Medtronic
  • Merck & Co., Inc.
  • Terumo Corporation
  • Medline Industries, LP
  • Cardinal Health
  • Boston Scientific Corporation
  • Teleflex Incorporated
  • CONMED Corporation
  • Dolphin surgical industries
  • Goodhealth Inc.
  • BioTek Instruments, Inc. (A subsidiary of Agilent Technologies, Inc.)